Related Experiment Videos
Large-cell medulloblastoma with arrestin-like protein expression
S Vincent1, M Mirshari, C Nicolas
1Neuropathology Department, CHRU Lille, France.
Clinical Neuropathology
|March 6, 2003
Summary
This study details a rare cerebellar large-cell medulloblastoma case in a child. Despite aggressive treatment, the patient succumbed, highlighting the aggressive nature of this specific tumor type.
Area of Science:
- Neuro-oncology
- Molecular pathology
- Pediatric oncology
Background:
- Medulloblastoma is a common malignant brain tumor in children.
- Large-cell medulloblastoma is a rare subtype with aggressive behavior.
- Genetic alterations, such as isochromosome 17q, are crucial in medulloblastoma pathogenesis.
Observation:
- A 12-year-old patient presented with cerebellar large-cell medulloblastoma.
- Despite gross-total resection, radiation, and chemotherapy, the patient died within 6 months.
- Immunohistochemistry revealed neuronal differentiation markers (synaptophysin, neurofilaments, chromogranin) and arrestin-like proteins.
- Genetic analysis identified an isochromosome 17q.
- Reverse transcription polymerase chain reaction (RT-PCR) detected mRNA for beta1 and beta2 arrestin, but not visual arrestin.
Findings:
- The large-cell medulloblastoma with isochromosome 17q exhibited neuronal differentiation.
- The tumor displayed non-photoreceptor characteristics.
- Arrestin immunoreactivity was attributed to non-visual arrestin subtypes (beta1 and beta2).
- The findings suggest a potential link to beta2 adrenergic receptors.
Implications:
- This case may represent a distinct clinicopathological entity of large-cell medulloblastoma.
- Further molecular characterization is needed to understand the role of beta2 adrenergic receptor-linked markers.
- Identifying novel therapeutic targets in aggressive medulloblastoma subtypes is critical.